CI
ZBH icon

Cavalier Investments’s Zimmer Biomet ZBH Stock Holding History

Cavalier Investments’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,716
Closed -$217K – 159
2016
Q3 		$217K Buy
+1,716
New +$212K 0.13% 116

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Cavalier Investments's ZBH Position: Q4 2016 in Review

Cavalier Investments sold out of Zimmer Biomet (ZBH) in Q4 2016, closing a stake of 1,716 shares — an estimated $217K sold.

Cavalier Investments first reported a position in ZBH in Q3 2016 and held it in 1 quarter. The position peaked at $217K in Q3 2016. 812 funds tracked by Wall St. Rank hold ZBH as of Q4 2016.

  • Cavalier Investments reported no remaining Zimmer Biomet position as of Q4 2016 after selling out during the quarter.
  • Cavalier Investments sold 1,716 Zimmer Biomet shares in Q4 2016, an estimated $217K.
  • Cavalier Investments first reported a position in Zimmer Biomet in Q3 2016 and held it in 1 quarter.
  • Cavalier Investments's Zimmer Biomet position peaked at $217K in Q3 2016.
  • 812 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2016.

Based on Cavalier Investments's 13F filing for Q4 2016, filed 3 Feb 2017.